substance p has been researched along with Adverse Drug Event in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, HJ; Cho, SS; Kim, HH; Ko, YH; Park, HS; Shim, BY; Sun, S; Won, HS | 1 |
| Hesketh, PJ | 1 |
1 review(s) available for substance p and Adverse Drug Event
| Article | Year |
|---|---|
Understanding the pathobiology of chemotherapy-induced nausea and vomiting. Providing a basis for therapeutic progress.
Topics: Antiemetics; Drug-Related Side Effects and Adverse Reactions; Humans; Models, Biological; Nausea; Neurokinin-1 Receptor Antagonists; Serotonin; Serotonin Receptor Agonists; Substance P; Vomiting | 2004 |
1 other study(ies) available for substance p and Adverse Drug Event
| Article | Year |
|---|---|
Elevated serum substance P level as a predictive marker for moderately emetogenic chemotherapy-induced nausea and vomiting: A prospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug-Related Side Effects and Adverse Reactions; Emetics; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasms; Prognosis; Prospective Studies; Substance P; Survival Rate; Vomiting | 2021 |